EVISIONS LLC – Trademark Portfolio
Entity Type: 16
EVISIONS LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DORIS, CADMUS, and EVISIONS. The owner is based in IRVINE, CA.
440 EXCHANGE, SUITE 200
IRVINE, CA 92602
Showing of trademarks Trademarks
Trademark Classifications
EVISIONS LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does EVISIONS LLC have?
EVISIONS LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does EVISIONS LLC file in?
EVISIONS LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are EVISIONS LLC's most well-known trademarks?
EVISIONS LLC's registered trademark portfolio includes well-known marks such as DORIS, CADMUS, and EVISIONS. These are among 3 currently registered trademarks in the portfolio.
What is EVISIONS LLC's trademark registration success rate?
EVISIONS LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.